accordingly
adenocarcinoma
adenocarcinomas
aggressiveness
autocrine
biomarker
contributing
detectable
egf
egfr
erlotinib
establishing
hb
her3
highlight
lung
mmp1
modulated
neoplastic
neuregulin
neurotensin
oncogenic
paracrine
pejorative
prognosis
sustained
void
xenografted
|